Approvals/TGA/ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe

Approved

STANDARD

ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe

Sanofi-Aventis Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 5d60d71ea7ebf97b
Product Name: ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe
Artg Id: 209224
Artg Name: ALPROLIX eftrenonacog alfa (rhu) 1000 IU powder for injection vial and diluent pre-filled syringe
Sponsor: Sanofi-Aventis Australia Pty Ltd
Company Detail Path: /organization/sanofi-aventis-australia-pty-ltd
Artg Date: 2014-05-01
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-CMI-01157-1
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-01156-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

5d60d71ea7ebf97b

Type

Standard